Mayaro	B-Reagent
virus	I-Reagent
real-time	B-Method
RT-PCR	I-Method
-	I-Method
2016	I-Method
method	I-Method

Assay	B-Action
has	O
been	O
used	O
on	O
both	O
a	O
Rotor-Gene	B-Device
6000	I-Device
/	O
Rotor-Gene	B-Device
Q	I-Device
5-plex	I-Device
using	O
100-place	B-Device
rotor	I-Device
discs	I-Device
.	O

Total	B-Reagent
reaction	I-Reagent
volume	B-Measure-Type
is	O
20	B-Amount
L	I-Amount
.	O

Prepare	B-Action
sufficient	O
for	O
number	O
of	O
reaction	B-Reagent
plus	O
a	O
'dead	B-Measure-Type
volume	I-Measure-Type
'	O
usually	O
2	B-Numerical
extra	O
.	O

Adjust	B-Action
as	O
necessary	O
if	O
using	O
a	O
robotic	B-Device
dispenser	I-Device
.	O

Dispense	B-Action
15	B-Amount
L	I-Amount
to	O
each	B-Modifier
reaction	B-Location
well	I-Location
.	O

Add	B-Action
5	B-Amount
L	I-Amount
of	O
template	B-Reagent
,	O
extracted	B-Modifier
DNA	B-Reagent
,	O
controls	B-Reagent
or	O
NTC	B-Reagent
(	O
nuclease-free	B-Modifier
water	B-Reagent
)	O
.	O

Total	B-Reagent
reaction	I-Reagent
volume	B-Measure-Type
is	O
20	B-Amount
L	I-Amount

PCR	B-Method

The	O
definition	O
used	O
for	O
a	O
satisfactory	O
positive	O
result	O
from	O
a	O
real-time	B-Method
fluorogenic	I-Method
PCR	I-Method
should	O
include	O
each	O
of	O
the	O
following	O
:	O

A	O
sigmoidal	B-Measure-Type
curve	I-Measure-Type
the	O
trace	B-Measure-Type
travels	O
horizontally	O
,	O
curves	O
upward	O
,	O
continues	O
in	O
an	O
exponential	O
rise	O
and	O
followed	O
by	O
a	O
curve	O
towards	O
a	O
horizontal	B-Measure-Type
plateau	I-Measure-Type
phase	O

A	O
suitable	O
level	O
of	O
fluorescence	B-Measure-Type
intensity	I-Measure-Type
as	O
measured	B-Action
in	O
comparison	O
to	O
a	O
positive	B-Reagent
control	I-Reagent
(	O
y-axis	B-Measure-Type
)	O

A	O
defined	O
threshold	B-Measure-Type
(	I-Measure-Type
CT	I-Measure-Type
)	I-Measure-Type
value	I-Measure-Type
which	O
the	O
fluorescent	B-Measure-Type
curve	I-Measure-Type
has	O
clearly	O
exceeded	O
(	O
Fig.1	O
arrow	O
)	O
and	O
which	O
sits	O
early	O
in	O
the	O
log-linear	B-Measure-Type
phase	I-Measure-Type
and	O
is	O
<	B-Modifier
40	B-Generic-Measure
cycles	I-Generic-Measure

A	O
flat	B-Measure-Type
or	O
non-sigmoidal	B-Measure-Type
curve	I-Measure-Type
or	O
a	O
curve	O
that	O
crosses	O
the	O
threshold	O
with	O
a	O
CT	B-Measure-Type
value	O
>	B-Modifier
40	B-Generic-Measure
cycles	I-Generic-Measure
is	O
considered	O
a	O
negative	O
result	O

NTCs	B-Reagent
should	O
not	O
produce	B-Action
a	O
curve	B-Measure-Type

Examples	O
of	O
satisfactory	B-Modifier
sigmoidal	B-Measure-Type
amplification	I-Measure-Type
curve	I-Measure-Type
shape	I-Measure-Type
when	O
considering	O
an	O
assay	B-Method
s	I-Method
fluorescent	B-Measure-Type
signal	I-Measure-Type
output	I-Measure-Type
.	O

The	O
crossing	B-Measure-Type
point	I-Measure-Type
or	O
threshold	B-Measure-Type
cycle	I-Measure-Type
(	I-Measure-Type
CT	I-Measure-Type
)	I-Measure-Type
is	O
indicated	O
(	O
yellow	O
arrow	O
)	O
;	O
it	O
is	O
the	O
value	O
at	O
which	O
fluorescence	B-Measure-Type
levels	I-Measure-Type
surpass	O
a	O
predefined	O
(	O
usually	O
set	O
during	O
validation	B-Method
,	O
or	O
arbitrary	O
)	O
threshold	B-Measure-Type
level	I-Measure-Type
as	O
shown	O
in	O
this	O
normalized	B-Measure-Type
linear	I-Measure-Type
scale	I-Measure-Type
depiction	O
.	O

LP-log-linear	B-Measure-Type
phase	I-Measure-Type
of	O
signal	O
generated	B-Action
during	O
the	O
exponential	O
part	O
of	O
the	O
PCR	B-Method
amplification	I-Method
;	O
TP-a	O
slowing	O
of	O
the	O
amplification	B-Method
and	O
accompanying	O
fluorescence	B-Measure-Type
signal	I-Measure-Type
marks	O
the	O
transition	B-Measure-Type
phase	I-Measure-Type
;	O
PP-the	B-Measure-Type
plateau	I-Measure-Type
phase	I-Measure-Type
is	O
reached	O
when	O
there	O
is	O
little	O
or	O
no	O
increase	O
in	O
fluorescent	B-Measure-Type
signal	I-Measure-Type
despite	O
continued	B-Modifier
cycling	B-Action
.	O



